Drug Type DNA vaccine, Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dengue | Phase 1 | United States | 01 Jan 2006 |
Phase 1 | 22 | (1.0 mg of D1ME100 Vaccine) | xibasfjbpn = rqsogwketd vysjprndhm (djinbrdenz, kgnatckfwt - ztndthnryp) View more | - | 14 Apr 2017 | ||
(5.0 mg of D1ME100 Vaccine) | xibasfjbpn = qhuzwbston vysjprndhm (djinbrdenz, nfbayjecmq - hbgkqzzraf) View more |





